Download PDF

Register to download the report. Already a member?

Sign Up


65992 1510824253HCLSReviewUkraineNovember2017.pdf
Energy Boardroom

Pharma Stories & Articles


Gender Diversity in Indian Pharma

India could boost its GDP by USD 0.7 trillion in 2025 by matching the rate of improvement of gender equality of the leading country in its region. Despite the prevalence of gender disparity in India, where only two percent of …


Ukraine: Outsourcing Public Procurement

Ukraine’s bold decision to outsource public procurement of medicines to international agencies to combat rampant corruption has been well received by the pharma MNCs operational in the country, but faces criticism from domestic players. “Healthcare procurement was widely considered as …


Canada: Safeguarding Generics

With cost-cutting measures exacerbating an already fraught regulatory process, the Canadian generics industry is facing somewhat of an existential crisis. However, within this difficult market environment, enterprising generics companies are still seeing significant opportunities for growth. “Sometimes it seems as …


Colombia: The Great Indian Investment Wave

With the onset of universal public healthcare, new types of foreign actors have been spying fresh opportunities to penetrate the Colombian market. Inward investment from India, in particular, has been increasing year on year, while the number of government sponsored …


Tunisia: Diabetes on the Rise

Diabetes is an important problem in Tunisia, with prevalence is expected to increase over the coming years. Jean-Francois Courtet, general manager of Novo Nordisk in Tunisia, points out rgar “diabetes is the second largest cause of death in Tunisia”. Moez …


India: Creating An Innovative Healthcare Ecosystem

At the Organization of Pharmaceuticals Producers of India (OPPI), the association representing the research-based pharmaceutical companies in India, putting the patient at the center of all that they do is part of their DNA. On the occasion of their 51st …


Colombia: Ramping up the Local Footprint

With Latin America’s best healthcare system in terms of both coverage and quality, Colombia is fast becoming a destination of choice for multinationals, not only to set up shop in the sense of establishing a direct local affiliate, but also …


Tunisia: A New Framework for Biotech Investments

The long-awaited conference marking the launch of the company cluster of Sidi Thabet (a city in the governorate of Ariana, 20 minutes from Tunis airport) took place on September 28th 2017 at the Tunis export centre (CEPEX) and revolved around …


Austria: Nucleus of Clinical Trials

Like a family recipe that has been refined and perfected over countless generations, Austria has developed a reputation as the quintessential clinical trials destination; a perfect combination of world-class academia, willing volunteers and educated medical personnel balanced against a backdrop …


Austria: Orchestrating Innovation

Austria has long been merely a cog in the wheel of global R&D, lying in the shadows of neighboring research giants, Germany and Switzerland. Now, however, this perception is changing as Austria capitalizes on its ideal central European location and …


Euratom: Where Are We Now?

Hamid Yunis, partner and head of healthcare at the London office of international law firm, McDermott Will & Emery, discusses the potential negative impact of Brexit and the UK leaving the European Atomic Energy Community (Euratom) on cancer care in …


Hong Kong: A Clinical Trials Destination

Small markets must inevitably etch out a niche positioning for themselves, and for Hong Kong, its world-class medical infrastructure, world-renowned academics and clinicians as well as high population density make it a strong contender in clinical research. “Hong Kong is …




Most Read

Download PDF

First Name:

Last Name: